Journal
ANNALS OF NEUROLOGY
Volume 53, Issue -, Pages S100-S107Publisher
WILEY
DOI: 10.1002/ana.10484
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS002122, U01NS043128] Funding Source: NIH RePORTER
- NINDS NIH HHS [U01 NS43128, K24 NS02122] Funding Source: Medline
Ask authors/readers for more resources
A major goal of the neuroscience community is to develop neuroprotective treatment strategies that will slow or forestall the progression of Parkinson's disease, one of the most common adult-onset neurodegenerative disorders, affecting approximately 1 million people in North America. Although prior research to identify neuroprotective interventions has not been conclusive, recent advances in the understanding of the pathogenesis of Parkinson's disease, including the development of relevant animal models, provide the opportunity for rational clinical trials to assess neuroprotective treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available